坎普托塞辛的奇拉尔纳米纤维触发了用于增强免疫治疗的热致死
Fengli Gao1, Xiaxin Qiu1, Sravan Baddi1
1State Key Lab of Metal Matrix Composites, School of Materials Science and Engineering, Shanghai Key Laboratory for Molecular Engineering of Chiral Drugs, Shanghai Jiao Tong University, Shanghai, 200240, China.
Angewandte Chemie (International ed. in English)
|January 13, 2025
概括
基拉尔坎普托西因纳米纤维 (CNF) 通过提高溶解度和激活免疫反应来增强药物输送和癌症免疫疗法. 这种新的方法克服了传统坎普托塞辛 (CPT) 的局限性,以更好地抑制瘤生长.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 癌症治疗 癌症治疗
背景情况:
- 坎普托西因 (CPT) 是一种强大的化疗剂,具有显著的抗癌潜力.
- CPT面临的挑战包括水溶性差,生物可用性有限,免疫刺激不足等.
- 克服这些局限性对于提高CPT临床疗效至关重要.
研究的目的:
- 开发使用超分子自我组装的性坎普托塞辛纳米纤维 (CNF),以增强CPT的治疗特性.
- 研究CNF在癌症治疗中的向传递和免疫调节效应.
- 评估CNF作为下一代免疫治疗策略的潜力.
主要方法:
- 超分子自我组装被用来构建右手性CPT纳米纤维 (CNF).
- CNF被配制为针对线粒体的DSPE-PEG-TPP,用于特定的癌细胞积累.
- 评估了CNF对反应性氧物种 (ROS) 生成,热,免疫细胞两极分化和瘤生长的影响.
主要成果:
- CNF表现出更好的水溶性和稳定性,克服了CPT的局限性.
- 线粒体对CNF的向导致ROS生成显著增加 (3.42倍) 和诱导热.
- 治疗CNF促进了M1巨细胞的两极分化,并增强了CD8+T细胞介导的抗瘤免疫力,从而抑制了瘤生长的1.8倍,并减少了转移.
结论:
- 奇拉 CNF 是一个创新的平台,可以克服 CPT 的临床局限性.
- 开发的CNF配方通过向药物输送和免疫系统调节来增强抗癌疗效.
- 这种方法为开发先进的癌症免疫疗法提供了一个有希望的新方向.
相关概念视频
01:27Tumor Immunotherapy
469
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
469
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
147
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
147